#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15264	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2516	737.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1655	1655	C	966	C,T	964,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15264	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2516	737.9	0	HET	.	.	.	C611T,A	.	611	611	C	1082	1082	C	926	C,T,A	493,432,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25404	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3896	810.4	0	.	n	.	0	T695C	SNP	695	695	T	1201	1201	C	926	C,T,A	922,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25404	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3896	810.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1843	1843	A	1093	A,C,T,G	1089,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25404	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3896	810.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2477	2477	C	888	C,T,A	885,1,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25404	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3896	810.4	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3103	3103	T	861	T,G	860,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25404	23S	2890	2890	99.86	23S.l6.c17.ctg.1	3896	810.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2551	2551	A	804	A,T,C	802,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2266	folP	852	852	100.0	folP.l15.c4.ctg.1	2035	139.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1255	1257	AGC	225;225;224	A,C;G;C,T	224,1;225;223,1	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6216	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3802	203.6	1	SNP	p	S91F	0	.	.	271	273	TCC	798	800	TCC	228;227;227	T;C;C	227;227;227	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6216	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3802	203.6	1	SNP	p	D95N	0	.	.	283	285	GAC	810	812	GAC	232;233;235	G,C;A,C;C	231,1;231,1;234	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6216	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3802	203.6	1	SNP	p	D95G	0	.	.	283	285	GAC	810	812	GAC	232;233;235	G,C;A,C;C	231,1;231,1;234	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	2232	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1932	144.2	1	SNP	p	G45D	1	.	.	133	135	GAC	814	816	GAC	242;244;246	G;A,C;C	242;243,1;246	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1258	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1371	114.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5508	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3586	191.7	1	SNP	p	D86N	0	.	.	256	258	GAC	864	866	GAC	244;243;242	G;A,C;C	244;242,1;242	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5508	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3586	191.7	1	SNP	p	S87I	0	.	.	259	261	AGT	867	869	AGT	240;238;244	A;G,T;T	240;237,1;244	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5508	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3586	191.7	1	SNP	p	S87R	0	.	.	259	261	AGT	867	869	AGT	240;238;244	A;G,T;T	240;237,1;244	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5508	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3586	191.7	1	SNP	p	S87W	0	.	.	259	261	AGT	867	869	AGT	240;238;244	A;G,T;T	240;237,1;244	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5508	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3586	191.7	1	SNP	p	S88P	0	.	.	262	264	TCC	870	872	TCC	246;247;250	T,A;C,A;C,A	245,1;246,1;249,1	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4780	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3236	184.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1854	1856	GGC	276;277;272	G,T;G,T;C,A	275,1;276,1;270,2	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2963	181.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1530	1532	GCA	234;231;230	G;C;A	234;231;230	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2963	181.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1533	1535	ATC	232;234;234	A,C;T;C	231,1;234;234	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2963	181.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1545	1547	GTG	230;233;230	G;T;G	230;233;230	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2963	181.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1545	1547	GTG	230;233;230	G;T;G	230;233;230	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2963	181.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2049	2051	ACC	252;252;249	A,G;C,T;C	251,1;251,1;249	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2963	181.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2103	2105	GCG	251;247;246	G,A;C,A;G	250,1;246,1;246	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2963	181.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2103	2105	GCG	251;247;246	G,A;C,A;G	250,1;246,1;246	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2963	181.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2226	2228	GGC	234;237;241	G,A;G;C,G	233,1;237;240,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2963	181.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2235	2237	GGC	248;248;250	G,T;G,T;C,T,G	247,1;247,1;248,1,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4314	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2963	181.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2253	2255	CCG	235;237;236	C,G;C,A;G,C	232,3;236,1;235,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5954	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3553	208.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1895	1897	CTG	240;243;243	C,T;T,G;G	239,1;242,1;243	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2758	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2200	156.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	785	785	C	204	C	204	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	E48G	NONSYN	142	144	GAA	600	602	GGA	234;234;234	G,T;G;A	233,1;234;234	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	V75I	NONSYN	223	225	GTT	681	683	ATT	249;250;252	A;T,C;T	249;249,1;252	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	T89S	NONSYN	265	267	ACC	723	725	AGC	254;253;254	A,C;G;C	253,1;253;254	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	V98I	NONSYN	292	294	GTC	750	752	ATC	272;276;273	A;T,G;C,T,G	272;275,1;271,1,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	.	MULTIPLE	358	359	AA	815	816	CG	242;243	C;G	242;243	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	.	MULTIPLE	361	362	GA	818	820	CAG	246;247;251	C;A,C;G	246;246,1;251	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	N122K	NONSYN	364	366	AAC	822	824	AAA	250;250;250	A;A;A	250;250;250	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	K143E	NONSYN	427	429	AAA	885	887	GAA	215;214;214	G;A;A,C	215;214;213,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	V151A	NONSYN	451	453	GTA	909	911	GCA	228;224;228	G;C,A;A	228;223,1;228	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	T213S	NONSYN	637	639	ACA	1095	1097	TCA	290;289;289	T,C;C;A,T	289,1;289;288,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1215	1217	CAA	225;221;219	C;A;A	225;221;219	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	.	INDELS	760	762	ACA	1219	1223	ATCAA	211;208;208;206;205	A,T;T;C;A;A	210,1;208;208;206;205	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	.	INDELS	763	764	TG	1226	1228	AGT	200;202;201	A;G,T;T	200;201,1;201	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1233	1235	GAT	206;206;208	G,T,C;A;T	204,1,1;206;208	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1341	1343	AGT	259;261;260	A;G;T	259;261;260	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1347	1349	GAC	262;265;267	G,T;A;C,A	261,1;265;266,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	0	.	p	.	0	H296Y	NONSYN	886	888	CAC	1350	1352	TAC	266;271;271	T;A,G;C,A	266;270,1;270,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	1	SNP	p	G120K	1	.	.	358	360	AAG	815	817	CGG	242;243;245	C;G;G	242;243;245	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	1	SNP	p	A121D	1	.	.	361	363	GAC	818	821	CGC	246;251;251	C;G;C	246;251;251	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2952	porB1b	1041	1041	97.23	porB1b.l15.c17.ctg.1	1649	217.8	1	SNP	p	D121N	0	.	.	361	363	GAC	818	821	CGC	246;251;251	C;G;C	246;251;251	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	560	288	porB3	990	162	93.83	porB3.l15.c4.ctg.4	163	59.8	0	.	p	.	0	S273T	NONSYN	817	819	TCG	61	63	ACT	78;78;78	A;C;T	78;78;78	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	560	288	porB3	990	162	93.83	porB3.l15.c4.ctg.4	163	59.8	0	.	p	.	0	D276S	NONSYN	826	828	GAT	70	72	AGT	78;78;78	A;G;T	78;78;78	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	560	288	porB3	990	162	93.83	porB3.l15.c4.ctg.4	163	59.8	0	.	p	.	0	K278D	NONSYN	832	834	AAA	76	78	GAC	78;78;78	G,T;A;C,A	77,1;78;77,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	560	288	porB3	990	162	93.83	porB3.l15.c4.ctg.4	163	59.8	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	79	81	TAC	78;78;78	T;A;C	78;78;78	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	9678	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5499	219.5	0	.	p	.	0	P1141L	NONSYN	3421	3423	CCG	3982	3984	CTG	246;247;251	C;T,G;G,T	246;246,1;250,1	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	9678	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5499	219.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2218	2220	AAT	251;252;253	A,T;A;T,G	250,1;252;252,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1544	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1417	135.5	1	SNP	p	V57M	1	.	.	169	171	ATG	750	752	ATG	272;273;273	A;T;G	272;273;273	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
